Related Experiment Video
Updated: Jan 20, 2026

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
Heart Failure in Women Due to Hypertensive Heart Disease
Jennifer Ballard-Hernandez1, Dipti Itchhaporia2
1Department of Medicine, Cardiology Division, U.S. Department of Veterans Affairs, VA Long Beach Healthcare System, 1 Hoag Drive, Newport Beach, CA 92663, USA.
Insights
Heart failure (HF) significantly impacts women
Area of Science:
- Cardiology
- Women's Health
- Medical Research
Background:
- Heart failure (HF) is a major cause of death and illness in US women.
- Sex-specific differences exist in HF etiology, progression, and outcomes.
- HF with preserved ejection fraction (HFpEF) is common in women, often linked to hypertensive heart disease.
Purpose of the Study:
- To highlight sex-specific differences in heart failure (HF).
- To address the lack of evidence for sex-specific HF therapies.
- To emphasize the need for further research on targeted HF treatments for women.
Main Methods:
- Review of existing literature on sex differences in heart failure.
- Analysis of current practice guidelines for HF management.
- Examination of women's representation in HF clinical trials.
Main Results:
- Current guidelines lack sex-specific recommendations for HF therapy.
- Women are underrepresented in HF clinical trials.
- Evidence for targeted HF therapies in women is insufficient.
Conclusions:
- There is a critical need for sex-specific research in heart failure.
- Clinical trials must increase female participant representation.
- Developing targeted HF therapies for women is essential for improving outcomes.
Abstract:
Heart failure (HF) is a significant cause of cardiovascular morbidity and mortality for women in the United States. There are clear sex-specific differences between men and women in etiology, disease progression, and outcomes. HF with preserved ejection fraction is the most common type of HF in women, with hypertensive heart disease playing a pivotal role in its etiology. The Practice Guidelines do not endorse sex-specific recommendations for standard medical therapy of HF management. Women are underrepresented in HF clinical trials, leading to a lacking evidence base supporting sex-specific therapy. Further studies are needed to evaluate targeted HF therapies in women.
More Related Videos
07:41A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
Related Concept Videos
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
07:41A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
07:49A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models
07:27Implantation of Total Artificial Heart in Congenital Heart Disease
09:23Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Heart Failure II: Pathophysiology